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Abstract
The replication dynamics of simian immunodeficiency virus (SIVmac32H-C8), attenuated through discrete genetic disruption of the nef
gene, were compared with the wild-type parental clone (SIVmac32H-J5) using quantitative molecular methods. The primary viraemia of
both infections were similar during the first week, but peaked on Day 10 at higher levels for wild-type virus. Viral RNA levels differed most
markedly at Day 14. The frequency and levels of viral DNA species, detectable as gag provirus or circular 2-LTR episomes, differed
depending on the virus and the lymphoid compartment sampled. 2-LTR circles persisted for prolonged periods in the peripheral blood but
were never detected in any SIVmac32H C8-infected tissue, even if positive by gag PCR. Paradoxically, the converse was observed
following wild-type infection. 2-LTR circles disappeared from the peripheral blood by Day 42 postinfection but persisted in lymphoid
tissues. These findings are discussed in terms of nef and the role and stability of 2-LTR circle forms in vivo.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The initial interactions between virus and host are critical
in determining the clinical outcome of human immunode-
ficiency virus type 1 (HIV-1) infection. Using highly sen-
sitive molecular assays, the dynamics of the early replica-
tive biology of primary HIV-1 infection have been
characterised (Lindback et al., 2000; Schacker et al., 1998)
and the determination of virus “set-point” levels in the
post-seroconversion period have proved invaluable in pre-
dicting subsequent clinical outcome and disease progression
(Cao et al., 1995; Mellors et al., 1996). However, the es-
tablishment of virus in other body compartments, such as in
lymphoid tissues, and the difficulty of obtaining appropriate
clinical samples prior to seroconversion means that we must
turn to animal models to investigate the early pathology of
lentivirus infection in detail. In particular, simian models
have been used to further characterise primary immunode-
ficiency virus infection (Lifson et al., 1997; Strapans et al.,
1999; Watson et al., 1997) and allow early events to be
dissected with the aim of identifying molecular markers in
peripheral blood samples that, in conjunction with the mea-
surement of plasma viral RNA, may provide additional
prognostic indicators to determine the rate of progression to
disease and insights into the early pathogenesis of HIV/SIV.
Two molecular clones have been isolated from the 11/88
pool of SIVmac32H (Rud et al., 1994). The replication of
one of these clones, SIVmac32H-C8, is attenuated in vivo
when compared with the second clone, SIVmac32H-J5. The
difference in replication can be accounted for by only seven
genetic differences restricted to the 3 nef/long terminal
repeat (LTR) region. The most notable difference in this
region is a 12 base-pair deletion that also results in the
deletion of a DMYL motif (amino acid 143-146) and mu-
tations R  K (amino acid 191) and T  A (amino acid
249) in the nef protein. Comparative studies of early events
following infection with these viruses reveal that both
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clones are established by Day 7 postinfection (p.i.), as
determined by in situ hybridisation and immuno-histo-
chemical analyses of gut-associated lymphoid tissue and
the frequency of infected cells detected in tissues follow-
ing either infection are similar (Canto-Nogues et al.,
2001 and unpublished observations). However, the viral
load in peripheral blood when measured by coculture
techniques at 2 weeks postinfection is 10- to 100-fold
lower in the attenuated SIVmac32H-C8 infection, com-
pared with the wild-type SIVmac32H-J5 virus infection
(Rud et al., 1994; Almond et al., 1995). Moreover,
SIVmac32H-C8-infected animals become virus-isolation
negative from Day 28 p.i., despite the persistence of viral
DNA in the blood over many months (Almond et al.,
1995).
One possible explanation that could account for the sus-
tained detection of a viral DNA signal in PBMC by DNA
PCR in the absence of any virus recoverable by coculture
may be that the viral DNA is not integrated as provirus. It
has been demonstrated for retroviruses that apart from in-
tegration, there are two other potential fates for viral DNA.
It can either remain as nonintegrated linear DNA or form
closed circular episomal species containing either one or
two long terminal repeat sequences (1- or 2-LTR circles)
(Farnet and Haseltine, 1991; Bukrinsky et al., 1992, 1993).
Detection of these replication intermediates has provided
additional information on the replicative biology and pa-
thology of HIV/SIV (Pauza et al., 1994; Polaciano et al.,
1995; Panther et al., 1999; Teo et al., 1997), and the levels
of these intermediates are known to fluctuate during the
natural course of HIV-1 infection and disease progression
(Jurrians and Goudsmit, 1996). However, while the precise
role of 1- and 2-LTR circles in vivo remains to be fully
elucidated, other proviral species such as linear unintegrated
DNA are considered to be the precursor to proviral integra-
tion (Chun et al., 1995). One possible reason for the failure
of retroviral DNA to integrate into the host cell genome may
be the failure of the host cell to be in an appropriate state of
activation (Spina et al., 1994). We therefore sought to de-
termine and compare the nature of the viral DNA species
associated with primary infection with wild-type
SIVmac32H-J5 and nef-attenuated SIVmac32H-C8. We
developed assays to detect and quantify 1-LTR and 2-LTR
DNA circles in the periphery and other lymphoid tissues
following infection of cynomolgus macaques and compared
these results with those obtained by quantification of plasma
viral RNA and total viral gag DNA levels in PBMCs. This
study identified notable distinctions between the patterns of
replication of wild-type and nef-disrupted attenuated SIVs
during the primary viraemic phase prior to seroconversion
and at later times that raise several questions as to the
functional role of nef in vivo and the implication of detect-
ing 2-LTR circles in clinical samples as a prognostic marker
of disease progression.
Results
Primary viraemia of SIVmac32H J5 and SIVmac32H C8
infection in Macaca fascicularis
Levels of plasma vireamia determined by RT-PCR fol-
lowing challenge with SIVmac32H-J5 (W250–W258) or
SIVmac32H-C8 (W255–W258) are presented in Fig. 1A.
Levels of SIV RNA for attenuated SIVmac32H-C8 paral-
leled those of wild-type SIVmac32H-J5, but never exceeded
them at any given time point. For both infections, a rapid
increase of vRNA load was detected during the first week
following challenge and reached a peak about 10 days
postinfection. The log10 mean peak loads for SIVmac32H-J5
and SIVmac32H-C8 were 6.35  0.23 and 5.47  0.15
RNA copies, respectively (unpaired Student’s t test, P 
0.01). Following this peak there was a more rapid reduction
in vRNA levels in attenuated SIVmac32H-C8 infections
compared with SIVmac32H-J5 between Days 10 and 14. At
Day 14 the greatest differential in vRNA loads between the
two infections was observed. Mean log10 vRNA loads at
Fig. 1. Plasma SIV RNA levels (A) and proviral gag and 2-LTR circle
DNA levels (B) measured over the first 42 days from challenge with
SIVmac32H J5 and SIVmac32H C8. SIV RNA levels are expressed as
copies per milliliter of plasma.
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Day 14 for SIVmac32H-J5 was 5.55  0.23 and for
SIVmac32H-C8 was 4.03  0.27 (unpaired Student’s t test,
P  0.001). Measured by coculture, the log10 titer of SIV
infection in PBMCs at this time was 2.5  1.08 for
SIVmac32H-J5 and 1.25  0.65 for SIVmac32H-C8 (un-
paired Student’s t test, P  0.09). After 14 days postinfec-
tion vRNA loads declined at a similar rate for both viruses,
becoming undetectable in SIVmac32H-C8 infections by
Day 42 and detectable sporadically in SIVmac32H-J5 in-
fections thereafter.
Levels of 2-LTR circle and gag proviral DNA in
peripheral blood during primary viraemia
Comparison of the levels of 2-LTR and gag signals was
made using parallel assay systems optimised for the detec-
tion and quantification of the different viral species in con-
junction with the plasmid constructs generated during the
study. A linear dose-response relationship was obtained
with both 2-LTR and gag assays over the same dynamic
range and comparable levels of sensitivity (Fig. 2). The
detection of SIV 2-LTR circles and SIV gag sequences were
examined in DNA extracted from blood collected during the
primary viraemia of attenuated SIVmac32H-C8 and wild-
type SIVmac32H-J5 (see Fig. 1B). No signal was detected
for either DNA species in materials collected 3 days postin-
fection. From Day 7 the profile of SIV gag DNA load
following infection with SIVmac32H-C8 was broadly sim-
ilar to that observed for SIVmac32H-J5, but peaked at a
lower level. At Day 14 postinfection, the mean log10 SIV
gag DNA copy number for SIVmac-J5 (4.75  0.02) was
significantly higher than that detected for attenuated
SIVmac32H-C8 (2.94  0.10) (unpaired Student’s t test, P
 0.001). Quantification of 2-LTR circles in DNA isolated
from the blood up to 28 days postinfection paralleled
closely levels of SIV gag sequences in the same DNA
samples. However, at Day 42 postinfection a marked dif-
ference in the detection of 2-LTR circles was observed in
attenuated SIVmac 32H-C8 infection when compared with
wild-type SIVmac 32H-J5. At this time, no 2-LTR circles
were detectable in samples of wild-type SIV infection,
whereas significant levels persisted in samples from atten-
uated virus infection.
Detection of SIV gag and 2-LTR DNA species in
lymphoid tissues
The surprising observation in differences in relative lev-
els of 2-LTR circle and SIV gag signals at key times in the
blood during primary viraemia led us to extend our study.
The presence of 2-LTR circles and SIV gag were investi-
gated in selected lymphoid tissues recovered from Macaca
fascicularis, killed humanely at various times during the
primary viraemia following inoculation with wild-type
SIVmac32H-J5 or attenuated SIVmac32H-C8. In addition,
the analysis was extended to investigate the presence of
1-LTR circle DNA species. No evidence of 1-LTR circle
was found in DNA derived from any tissue at any time
point. In contrast, 2-LTR circles were detected at various
time points (see Table 1). For wild-type SIVmac32H-J5
infection, 2-LTR circles were detectable in the mesenteric
lymph nodes at Day 4 albeit at low levels. By Day 14,
2-LTR circles were detectable in all tissues sampled (spleen,
MLN, PLN, and thymus) and selected tissues at Day 28. In
marked contrast, 2-LTR circles were never detected in DNA
recovered from any tissue or at any time point following
infection with attenuated SIVmac32H-C8.
2-LTR DNA species persist in the peripheral blood of
SIVmac32H-C8, but not SIVmac32H-J5 infections
The persistence of 2-LTR circles in the peripheral blood
following infection with SIVmac32H was investigated.
PCR-mediated analysis for SIV gag and 2-LTR circles was
undertaken in samples from blood and selected lymphoid
tissues 442 days after infection with wild-type SIVmac32H-J5
(R33–R36) and 526 days after infection with attenuated
SIVmac32H-C8 (R37–R40; see Table 2). For DNA samples
collected following wild-type SIVmac32H-J5 infection, both
2-LTR and SIV gag signals were detected in spleen, mes-
enteric, and peripheral lymph node from all macaques. In
samples collected from blood, no evidence of 2-LTR signals
were detected in three of four macaques. Intriguingly, the
anomalous result was obtained from macaque R33 for
which there was evidence of superinfection with SHIV89.6P
by diagnostic HIV-1 env DNA PCR (data not shown). In
marked contrast, analysis of blood and lymphoid tissues
from SIVmac32H-C8 infection presented a distinct pattern.
In spleen, mesenteric, and peripheral lymph nodes, no
2-LTR DNA species were detectable, whereas a significant
SIV gag signal persisted. In contrast, 2-LTR circles were
detectable in the blood at Day 526 and at comparable levels
to SIV gag signal. Hence, in DNA from blood in SIV-C8
infection, it is apparent that the majority of the SIV gag
Fig. 2. Standard curves of the signal, expressed as relative light units,
obtained using quantified plasmid control DNA (see Materials and meth-
ods) as template in DNA PCR for the detection and quantification of SIV
gag and 2-LTR circle DNA.
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Table 1
Levels of 2-LTR circles detected in lymphoid tissues and peripheral blood during the first 28 days p.i. with either SIVmac32H J5 or SIVmac 32H C8
Virus Day p.i. Animal No. Tissue
PBMC Spleen MLN PLN Thymus
J5 4 P213 2.25 1.69a 1.77 1.69a ND
P214 2.88 1.69a 1.70 1.69a ND
7 N17 3.25 1.69a 2.68 1.69a 1.69a
N18 3.32 1.69a 1.69a 1.95 1.69a
N19 3.28 — — — —
N20 1.69a — — — —
N21 2.95 — — — —
N22 3.26 — — — —
P215 3.23 2 2 2.08 ND
P216 2.95 1.69a 2.60 1.69a ND
14 N19 4.39 2 3.26 2.70 2.48
N20 4.29 2.65 2.95 2.60 1.95
N21 4.32 — — — —
N22 4.16 — — — —
28 N21 4.79 2.85 2.98 3.08 1.69a
N22 4.76 1.69a 1.69a 3.02 2.65
C8 4 P209 1.69a 1.69a 1.69a 1.69 ND
P210 1.69a 1.69a 1.69a 1.69 ND
7 N23 1.69a 1.69a 1.69a 1.69 1.69a
N24 1.69a 1.69a 1.69a 1.69 1.69a
N25 1.69a — — — —
N26 1.69a — — — —
N27 1.69a — — — —
N28 1.69a — — — —
P211 1.69a 1.69a 1.69a 1.69a ND
P212 1.69a 1.69a 1.69a 1.69a ND
4 N25 2.34 1.69a 1.69a 1.69a 1.69a
N26 1.69a 1.69a 1.69a 1.69a 1.69a
N27 2.25 — — — —
N28 3.16 — — — —
28 N27 2.90 1.69a 1.69a 1.69a 1.69a
N28 2.65 1.69a 1.69a 1.69a 1.69a
Note. Tissues examined were as follows: peripheral blood mononuclear cells (PBMCs), spleen, mesenteric lymph nodes (MLN), peripheral lymph nodes
(PLN), and thymus. Quantitative values are expressed as log10 copies per 105 cells. ND  not determined.
a Values less than log 1.69, equivalent to 50 copies per 105 cells, were below limits of detection.
Table 2
Levels of 2-LTR circle and gag DNA in lymphoid tissues and peripheral blood following chronic infection with either SIVmac32H J5 or
SIVmac32H C8
Virus Day Animal Tissue
PBMC Spleen MLN PLN
2LTR gag 2LTR gag 2LTR gag 2LTR gag
J5 442 R33a 2.92 3.36 2.97 3.33 3.09 3.36 3.26 3.52
R34 1.69b 2.36 2.57 2.73 2.55 2.81 2.57 2.85
R35 1.69b 2.56 2.58 2.79 2.73 3.01 2.65 2.92
R36 1.69b 2.51 2.32 2.62 2.74 3.03 2.49 2.86
C8 526 R37 1.95 2.04 1.69b 2.54 1.69b 2.34 1.69b 1.78
R38a 1.85 1.95 1.69b 1.95 1.69b 2.32 1.69b 2.51
R39a 2.32 2.63 1.69b 1.78 1.69b 1.84 1.69b 1.85
R40a 2.25 2.52 1.69b 2.50 1.69b 2.43 1.69b 2.49
Note. Postmortems were carried out on Days 442 (J5) and 526 (C8). Tissues examined were as follows: peripheral blood mononuclear cells (PBMC),
spleen, mesenteric lymph nodes (MLN), and peripheral lymph nodes (PLN). Quantitative values are expressed as log10 copies per 105 cells.
a Superinfection with SHIV89.6P on day 386.
b Values less than log 1.69, equivalent to 50 copies per 105 cells, were below the limits of detection.
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DNA signal is likely to be derived from 2-LTR circles
present in the sample.
Discussion
The replication dynamics of wild-type SIVmac32H-J5
and an attenuated counterpart SIVmac32H-C8, which differ
by virtue of minor genotypic changes of the nef gene, have
been compared. Quantitative RT-PCR and DNA PCR as-
says were employed, capable of measuring SIV RNA levels
in plasma, and the frequency and level of different forms of
SIV provirus, including 2-LTR circular episomal DNA and
total gag levels, in samples obtained from different body
compartments. Comparison of these different markers of
viral replication revealed that while the initial establishment
(4–7 days p.i.) with either virus is indistinguishable, quan-
tifiable differences in viral RNA and DNA load are apparent
by the peak viral load and thereafter (day 10 p.i. and on-
ward). The difference in peak viraemia reflects differences
in virus load measured by coculture of PBMC with appro-
priate indicator cells at Day 14 p.i. However, after 28 days
p.i. more marked differences in the detection of viral nucleic
acid species were observed that differentiated the wild-type
virus from its attenuated counterpart. At the end of the
period of primary viraemia, as determined by the decline in
plasma RNA levels, the amount of unintegrated DNA re-
covered from PBMC measurable by 2-LTR circle PCR
assays dropped to undetectable levels for wild-type
SIVmac32H-J5 infection. In marked contrast, 2-LTR circles
persisted in the peripheral blood of attenuated SIVmac32H-C8
infection and though unlikely to account for all proviral
species that could potentially be present, episomal forms of
DNA represent a significant proportion of the SIV DNA
detectable by SIV gag specific PCR. This observation is
supported by the ability to coamplify 2-LTR and gag target
sequences from the same plasmid construct (p2-LTR) de-
signed specifically for this purpose, utilising the same dilu-
tion series to derive each of the regression curves shown in
Fig. 2. Amplification and detection of either a 2-LTR or a
gag signal in independent assays using the different config-
urations of PCR primers is further validated by the obser-
vation that when DNA templates isolated ex vivo were
analysed using the same concentration of target DNA, the
value of 2-LTR circles never exceeded those obtained with
SIV gag target sequences. Hence, in peripheral blood in
SIVmac32H-C8 where the gag DNA signal persists, it is
apparent that this may be accounted for to a greater extent
by 2-LTR circular forms which are capable of persisting for
extended periods. Presumably this would also account for
the difficulty of reisolating virus from PBMC by coculture,
since this extrachromosomal circular DNA is highly un-
likely to yield infectious virus.
A quite different pattern emerged from the analysis of
lymphoid tissues. 2-LTR circles were never detected at any
time during the primary viraemia, nor at any time sampled
up to Day 526 p.i., in tissues infected with SIVmac32H-C8,
despite a persisting SIV gag signal, whereas high levels of
2-LTR circles were detected in tissues from Day 4 follow-
ing wild-type SIVmac32H-J5 infection and persisted
through to Day 442 p.i. As a result, we have a paradoxical
situation where attenuation leads to opposite effects on the
distribution of viral DNA species depending upon the cell
compartment analysed. While it was not unexpected that
infection with an attenuated virus would result in lower
plasma viral RNA and total SIV DNA loads during the
period of primary viraemia, it was unexpected, however,
that the production of 2-LTR signals would be so dramati-
cally affected in different body compartments. These obser-
vations add to recent reports (Butler et al., 2002; Cara et al.,
2002, Pierson et al., 2002) which suggest that a reevaluation
of the interpretation of detecting 2-LTR signals in vivo are
required, given their greater stability than hitherto envis-
aged. Such findings have important implications since
2-LTR assays are beginning to be used as a prognostic tool
to analyse disease progression among patients undergoing
highly suppressive anti-retroviral therapy (Sharkey et al.,
2000), where plasma viral RNA loads have been driven
down to undetectable levels and the analysis of cellular
nucleic acid components becomes desirable (Coffin, 1995).
In particular, our data point to a quite different pattern
emerging depending upon whether such signals are detected
in peripheral blood or another site. Certainly, the only body
compartment routinely measured in clinical practice is pe-
ripheral blood, which may not provide the most accurate
and complete picture of the distribution of different viral
species in all situations, given the stability of 2-LTR circles
in in vitro systems.
Clearly there are distinct patterns of viral replication
between the wild-type J5 virus and attenuated C8, where
there is a disruption to the nef gene. However, what is less
clear is whether the observed differences are as a direct
result of a disruption in nef function, or a more general
property of attenuated virus infection per se where the
biological effects of nef may be less important. Despite the
differential signals obtained from attenuated and wild-type
infections from Day 10 onward, it is noteworthy that the
initial establishment of the two virus infections were similar
in both timing and magnitude. This is intriguing, since on
the one hand it would imply that while a functional nef
protein is essential for the persistence of viral replication in
vivo, it is not crucial during the very earliest times. The
results presented in Fig. 1 summarising results from molec-
ular assays to characterise events in the peripheral blood are
supported by other molecular techniques such as in situ
hybridisation and immuno-histochemical analyses of lym-
phoid tissues (Canto-Nogues et al., 2001). Perhaps it is the
ability of this attenuated SIVmac32H-C8 to establish infec-
tion so effectively that accounts for the potent protection
conferred by this virus against superinfection with wild-type
SIVmac (Almond et al., 1995) and that this protection is
apparent by 10 weeks postinfection (Norley et al., 1996), or
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even sooner (Stebbings et al., unpublished data). Although
from this data the benefit of a functional nef is to enhance
virus replication from Day 10 p.i., this analysis does not
clearly determine how this is achieved and any explanation
requires some consideration of the functions of nef in vivo.
Functional studies describing the effects of the attenuat-
ing deletion DMYL in C8 nef with respect to wild-type
viruses have indicated that C8 nef has a reduced ability to
bind TCR zeta and down-modulate the TCR-CD3 complex,
which initiates the T cell signalling cascade (Bell et al.,
1998). This study also presents some evidence that C8 has
an impaired ability to down-modulate CD4, possibly due to
differences in protein folding. However, results from studies
describing the stability of C8-nef are unclear. C8-nef has
been reported to be less stable in in vitro systems, for
example, when expressed in 293T cells (Carl et al., 1999).
However, metabolic labelling studies of J5 and C8 nef in
preliminary studies to the application of recombinant vac-
cinia vectors to express SIVmac J5 or C8 nef to elicit CTLs
and protect against wild-type SIV (Gallimore et al., 1995)
indicate no marked difference in the relative breakdown or
intrinsic stability of the C8 nef protein compared with J5
even when overexpressed using recombinant vaccinia virus
vectors (Gallimore, 1995). These studies suggest that
though the C8 nef protein is expressed, it has an altered
ability to perform some of the key functions attributed to
wild-type nef viruses. Further investigations to identify the
crucial differences in the functional properties between J5
and C8 nef are currently on-going.
It could be that nef permits virus replication in cells that
would not be permissive without the presence of nef en-
hancing replication and increasing infectivity (Miller et al.,
1994; Heidecker et al., 1998), acting in the recruitment and
activation of additional cells to the site of virus replication
(Swingler et al., 1999) or by subverting or destroying ef-
fective antiviral immunity (Xu et al., 1997, 1999). While it
is possible that there are direct effects of nef allowing
enhancement of the infectivity of virus particles during the
process of cell entry or at a subsequent stage prior to
proviral integration possibly due to the presence of nef in
the virion (Schaeffer et al., 2001; Zhou and Aitken, 2001),
a more likely explanation for our findings is that nef plays a
role in substrate recruitment and mutant nef viruses have
reduced capacity to elicit widespread dissemination. The
expression of nef in infected cells in vivo may recruit and
activate uninfected neighbouring cells, increasing the like-
lihood that a productive infection cycle ensues (Swingler et
al., 1999). However, the fact that SIVmac32H-C8 infection
is well established in lymphoid tissues, yet 2-LTR circles
are not detectable, warrants further study and explanation.
Determination of which cell populations in the peripheral
blood are infected with C8 and the presence of 2-LTR circle
forms may also help to clarify issues of virus dissemination
and persistence. Similarly, whether alterations of 2-LTR
production is a property of all nef variants and viruses
attenuated through different means, such as SHIV-4 which
has a nonfunctional vpu gene (McCormick-Davis et al.,
1998) and replicates poorly in vivo (unpublished observa-
tions), requires further study.
If a virus expressing a disrupted nef gene will alter the
pattern of 2-LTR signal detection in the periphery, then a
failure to appreciate all the viral factors that influences the
production of these DNA species could result in inappro-
priate changes in clinical management being made that are
detrimental to the patient. Further investigations in clinical
studies and the use of model systems are clearly required to
unravel the implications of these intriguing observations.
Materials and methods
Plan of experiments
Purpose-bred juvenile cynomolgus macaques (M. fas-
cicularis) were used in all studies. All were negative for
simian D type retroviruses. They were housed and main-
tained in accordance with the U.K. Home Office guidelines
for the care and maintenance of nonhuman primates. All
macaques were sedated with ketamine hydrochloride before
inoculation with virus or venepuncture and killed humanely
by overdose of anaesthetic.
For the analysis of the primary viraemia, two groups of
four macaques were inoculated intravenously with 5  103
TCID50 of the 9/90 pools of SIVmac32H C8 (W250–
W253) or SIVmac32H J5 (W254–W257). At selected times
through to Day 42 p.i., samples of peripheral blood were
collected using EDTA as anticoagulant. Plasma was stored
for the recovery of viral RNA and total DNA prepared from
buffy coat cells as a template for DNA PCR reactions. For
the long-term persistence of SIV DNA signals, DNA was
collected from blood and selected lymphoid tissues of four
cynomolgus macaques (R33–R36) that had been killed hu-
manely 442 days after intravenous inoculation with 103
TCID50 of SIVmac32H-J5C pool of virus. This group had
been rechallenged with 500 TCD50 SHIVSF33 (Luciw et al.,
1995) on Day 296 and with 500 TCD50 SHIV89.6P
(Reimann et al., 1996) on Day 386 p.i. At the termination of
this study there was evidence that R33 had been superin-
fected with SHIV89.6P by diagnostic HIV-1 envelope PCR.
For the analysis of SIVmac32H-C8 infection, DNA samples
were used from four cynomolgus macaques (R37–R40) that
had been killed humanely by intravenous injection 526 days
after inoculation with SIVmac32H C8C pool. This group of
four macaques had been rechallenged intravenously with
103 TCD50 of SIVmac32H-J5C at Day 218 postinfection
and 103 TCID50 SHIV89.6P on Day 386 postinfection. At
termination there was no evidence that R37–R40 had been
superinfected with SIVmac32H-J5C, but at this time there
was evidence that R38–R40 had been superinfected with
SHIV89.6P by diagnostic HIV-1 envelope DNA PCR. For
the detection of SIV viral DNA species in the lymphoid
tissues of macaques during the primary viraemia, DNA was
105S. Clarke et al. / Virology 306 (2003) 100–108
derived from cynomolgus macaques inoculated intrave-
nously with either SIVmac32H-J5C (N17–N22, P213–
P216) or 103 TCID50 SIVmac32H-C8C (N23–N28, P209–
P212). For each virus, pairs of macaques were killed
humanely on Days 4, 7, 14, and 28 following inoculation
and DNA was prepared from spleen, thymus, peripheral,
and mesenteric lymph nodes prior to analysis by DNA PCR.
Plasmid construction
PCR-based assays were designed to detect and quantify
SIV DNA episomes which could be present as either 1- or
2-LTR circles. To enable this, a series of plasmids were
constructed by sequential cloning of PCR products to con-
trol for the amplification efficiency of 1- and 2-LTR circles
in PCR assays. An additional construct was made to control
for amplification of SIV gag. Subgenomic fragments of
SIVmac32H-J5 (nef-LTR, LTR-gag, and gag) were ampli-
fied from the plasmid pJ5T-KS-SIVmac32H (CFAR 229;
Centralised Facility for AIDS Reagents, NIBSC, UK) by
PCR using the following combination of primers: nef-LTR,
sense SN9015NE (5GAA TTC GAA TTC ATG GGT GGA
GCT ATT TCC AGG3) and antisense SL10263CSE
(5GAT ATC CCC GGG TGC TAG GGA TTT TCC3);
LTR-gag, sense SL001NSE (5GAT ATC CCC GGG TGG
AAG GGA TTT ATT ACA3) and antisense SG2053CX
(5CTC GAG CTC GAG ACC CAG TCC CTT CAG
TAC3); and gag, sense SG819NSE (5GAT ATC CCC
GGG GAT TGG CGC CTG AAC AGG3) and antisense
SG2053CX. Each product had a unique restriction site en-
gineered into the sequence and PCR was carried out in a
DNA thermal cycler (Hybaid, UK). Forty cycles of ampli-
fication were performed on 5 l samples of DNA in 50 l
of the following reaction mixture: 10 mM Tris–HCl, pH 8.3,
50 mM KCl, 1.8 mM MgCl2, 0.25 mM each respective
primer, 0.2 mM each of dATP, dCTP, dGTP, and dTTP, and
1.25 U Amplitaq Gold DNA polymerase (Perkin–Elmer,
Cheshire, UK). Each cycle consisted of 1 min denaturation
at 94°C, 2 min primer annealing at 60°C, and 3 min exten-
sion at 72°C. The PCR products were initially cloned into
pGemT-Easy (Promega, UK) creating pNEF-LTR, pLTR-
GAG, and pGAG, respectively.
Double digests of pNEF-LTR (SmaI and SalI) and
pGAG (SmaI and XhoI) were used to clone the gag frag-
ment from pGAG into pNEF-LTR to create the 1-LTR
control plasmid (p1-LTR). Double digests of pNEF-LTR
(SmaI and SalI) and pLTR-GAG (SmaI and XhoI) were used
to clone the LTR-gag fragment from pLTR-GAG into
pNEF-LTR to create the 2-LTR control plasmid (p2-LTR).
PCR amplification of SIV 1-LTR and 2-LTR circles and
gag from biological samples
1-LTR fragments (	850 bp) were amplified using the
primers SN9373N (5TAC CAG TGA TGC CAC GAG3,
sense) and SG842C (5CAC TCT CCT TCA AGT CCC3,
antisense), which recognise sequences in nef and gag, re-
spectively. The 2-LTR fragment (	300 bp) was amplified
using the primers SL10098N (5GGCTCCACGCTTGCTT-
GCTT3, sense) and SL163C (5CCT CCT GTG CCT CAT
CTG3, antisense), which recognise sequences in the U5 and
U3 regions, respectively. The gag sequence (146 bp) was
amplified using SG131N (5TTG GAT TAG CAG AAA
GCC TG3, sense) and SG277C (5TCT CTT CTG CGT
GAA TGC AC3, antisense).
PCR was carried out in a DNA thermal cycler (Hybaid).
Forty cycles of amplification were performed on aliquots (5
l) of DNA in 50 l of reaction mixture as described above.
For the 1-LTR circle PCR each cycle consisted of 1 min
denaturation at 94°C, 2 min primer annealing at 60°C, and
3 min extension at 72°C. For the 2-LTR circle and gag
PCRs each cycle consisted of 30 s denaturation at 94°C, 30 s
primer annealing at 60°C, and 30 s extension at 72°C for 40
rounds of PCR. The sequence and positions of the primers in
the SIVmac32H genome were based on the numbering system
for the published sequence of SIVmac32H.
Amplified products were analysed on 1.25% agarose gels
and visualised by UV illumination after treatment with
ethidium bromide. Southern hybridisation with SL10218N
(5GAC CCT GGT CTG TTA GGA CC 3) (for the 1-LTR
and 2-LTR amplified products) and SG176N (5AAT ACT
TTC GGT CTT AGC TC3) (for the gag amplified products)
confirmed that the bands represented the respective SIV
sequences.
Quantification of SIV 2-LTR circles and gag proviral
DNA and plasma viral RNA
Extracts of purified DNA obtained from PBMC or tis-
sues by overnight digestion in proteinase-K/SDS solution
followed by phenol/chloroform extraction and alcohol pre-
cipitation were used in conjunction with serial dilutions of
plasmid DNA controls. The amount of input DNA from
clinical samples was quantified prior to PCR amplification
by fluorometry. For quantitative 2-LTR circle measure-
ments, the antisense primer SL163C was 5 biotinylated and
the 2-LTR PCR repeated. Biotinylated PCR products were
captured onto streptavidin-coated wells in an enzyme-linked
oligonucleotide assay (ELONA). Amplicons were probed
with an alkaline phosphatase labeled probe with the same
sequence used in the SIV RNA assay (5TCCCATCTCTC-
CTAGTCGCCGCCT3) in a chemiluminescence-based
ELONA detection system as previously described (2). In
this manner, quantitative measurements of 2-LTR circles
were obtained. gag signals were similarly quantified using
the following primer combinations: the antisense primer
SG842C was 5 biotinylated and used in conjunction with
SL10098N. Southern hybridisation with SL10218N for both
2-LTR and gag PCR products demonstrated reproducible
results with those obtained with the ELONA system (results
not shown). Using p2-LTR, a dilution series (log10) ranging
from 10,000 to 1 copies per PCR was created for both
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2-LTR circles and gag to generate a standard curve.
Amounts of 2-LTR circles or gag present in samples were
compared with the standard curve and corrected to copies
per 105 PBMCs. Where samples were above the range of the
standard curve, the PCR product was diluted and the
ELONA repeated.
Plasma viraemia was assessed by reverse transcriptase
PCR (RT-PCR) using a quantitative SIV RNA assay mod-
ified from a previously described method (Berry et al.,
1998). Reverse transcription and PCR were performed with
avian myeloblastosis virus (AMV) reverse transcriptase and
Pwo/Taq DNA polymerases, using Titan reagents (Roche
Diagnostics, Branchburg, NJ) and long terminal repeat
primers. The amount of specific PCR product was similarly
quantified by hybridisation with alkaline phosphatase la-
beled probe and chemiluminescence in the ELONA system.
The SIV RNA assay detects vRNA levels greater than or
equal to 200 copies/ml of plasma.
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